<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.15833.004</object-id><label>Table 1.</label><caption><p>Suppressors and enhancers of <italic>dapk-1</italic> morphological defects.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15833.004">http://dx.doi.org/10.7554/eLife.15833.004</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Gene</th><th valign="top">Alleles and sequence change</th><th valign="top">Mammalian orthologs</th></tr></thead><tbody><tr><td colspan="3" valign="top">A. Suppressors (forward screen)</td></tr><tr><td rowspan="3" valign="top"><italic>ptrn-1</italic></td><td valign="top"><italic>ju698</italic></td><td rowspan="3" valign="top">CAMSAP/Patronin</td></tr><tr><td valign="top">*<italic>lt1</italic></td></tr><tr><td valign="top"><italic>tm5597</italic></td></tr><tr><td rowspan="2" valign="top"><italic>dhc-1</italic></td><td valign="top"><italic>ju697</italic></td><td rowspan="2" valign="top">Dynein heavy chain</td></tr><tr><td valign="top"><italic>*or195</italic>ts</td></tr><tr><td rowspan="2" valign="top"><italic>dapk-1</italic></td><td valign="top"><italic>ju1143</italic></td><td rowspan="2" valign="top">(intragenic)</td></tr><tr><td valign="top"><italic>ju1145</italic></td></tr><tr><td colspan="3" valign="top">B. Suppressors (candidates)</td></tr><tr><td valign="top"><italic>unc-116</italic></td><td valign="top"><italic>e2310</italic></td><td valign="top">Kinesin-1</td></tr><tr><td valign="top"><italic>sma-1</italic></td><td valign="top"><italic>e30</italic></td><td valign="top">Beta-heavy spectrin</td></tr><tr><td colspan="3" valign="top">C. Enhancers</td></tr><tr><td valign="top"><italic>klp-7</italic></td><td valign="top"><italic>tm2143</italic></td><td valign="top">Kinesin-13</td></tr><tr><td valign="top"><italic>mei-1</italic></td><td valign="top"><italic>or642</italic>ts</td><td valign="top">p60 katanin</td></tr><tr><td valign="top"><italic>spas-1</italic></td><td valign="top"><italic>tm683</italic></td><td valign="top">Spastin</td></tr><tr><td valign="top"><italic>cat-4</italic></td><td valign="top"><italic>tm773</italic></td><td valign="top">GTP cyclohydrolase I</td></tr><tr><td valign="top">F47G4.5</td><td valign="top"><italic>ok2667</italic></td><td valign="top">p80 katanin</td></tr><tr><td colspan="3" valign="top">D. No interaction</td></tr><tr><td valign="top"><italic>ebp-1</italic></td><td valign="top"><italic>tm1357</italic></td><td valign="top">Plus-end binding protein</td></tr><tr><td valign="top"><italic>ebp-2</italic></td><td valign="top"><italic>gk756</italic></td><td valign="top">Plus-end binding protein</td></tr><tr><td valign="top"><italic>ccpp-1</italic></td><td valign="top"><italic>ok1821</italic></td><td valign="top">Cytosolic Carboxypeptidase</td></tr><tr><td valign="top"><italic>ccpp-6</italic></td><td valign="top"><italic>ok382</italic></td><td valign="top">Cytosolic Carboxypeptidase</td></tr><tr><td valign="top"><italic>mcrs-1</italic></td><td valign="top"><italic>tm3681</italic></td><td valign="top">Microspherule Protein 1</td></tr><tr><td valign="top"><italic>efa-6</italic></td><td valign="top"><italic>tm3124</italic></td><td valign="top">EFA6</td></tr><tr><td valign="top"><italic>ttll-5</italic></td><td valign="top"><italic>tm3360</italic></td><td valign="top">Tubulin tyrosine ligase-like</td></tr><tr><td valign="top"><italic>ttll-11</italic></td><td valign="top"><italic>tm4059</italic></td><td valign="top">Tubulin tyrosine ligase-like</td></tr><tr><td valign="top"><italic>ttll-12</italic></td><td valign="top"><italic>tm4957</italic></td><td valign="top">Tubulin tyrosine ligase-like</td></tr><tr><td valign="top"><italic>unc-70</italic></td><td valign="top"><italic>e524</italic></td><td valign="top">&#946;-Spectrin</td></tr><tr><td valign="top"><italic>dylt-2</italic></td><td valign="top"><italic>gk762</italic></td><td valign="top">Dynein light chain</td></tr><tr><td valign="top">dnc-1</td><td valign="top"><italic>or404</italic>ts</td><td valign="top">p150 dynactin</td></tr><tr><td valign="top"><italic>nud-1</italic></td><td valign="top"><italic>ok552</italic></td><td valign="top">NDE1/NDEL1</td></tr><tr><td valign="top"><italic>nud-2</italic></td><td valign="top"><italic>ok949</italic></td><td valign="top">NDE1/NDEL1</td></tr><tr><td valign="top"><italic>unc-14</italic></td><td valign="top"><italic>e57</italic></td><td valign="top">kinesin-1 adaptor</td></tr><tr><td valign="top"><italic>tbg-1</italic></td><td valign="top"><italic>t1465</italic></td><td valign="top">&#947;-tubulin</td></tr><tr><td valign="top"><italic>ptl-1</italic></td><td valign="top"><italic>ok621</italic></td><td valign="top">tau</td></tr><tr><td valign="top"><italic>pinn-1</italic></td><td valign="top"><italic>tm2235</italic></td><td valign="top">Pin1</td></tr><tr><td valign="top"><italic>par-1</italic></td><td valign="top"><italic>zu310</italic>ts</td><td valign="top">MARK</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>Suppressors indicated * were tested for suppression of <italic>dapk-1(ju4)</italic> and <italic>dapk-1(gk219).</italic> Enhancers were tested with <italic>dapk-1(gk219)</italic>. Genes in section D were mostly tested for interaction with <italic>dapk-1(ju4). dapk-1 tbg-1</italic> double mutants were extremely sick, and a stable strain could not be obtained; n &gt; 100 animals scored per genotype.</p></fn></table-wrap-foot></table-wrap>